Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1959 1
1961 1
1962 7
1963 7
1964 3
1965 2
1966 4
1967 7
1968 4
1969 2
1970 6
1971 5
1972 10
1973 3
1974 7
1975 8
1976 5
1977 3
1978 3
1979 6
1980 5
1981 3
1982 6
1983 5
1984 6
1985 8
1986 13
1987 11
1988 13
1989 8
1990 11
1991 13
1992 18
1993 23
1994 16
1995 16
1996 14
1997 16
1998 23
1999 22
2000 46
2001 47
2002 49
2003 57
2004 74
2005 93
2006 105
2007 163
2008 154
2009 192
2010 227
2011 242
2012 243
2013 229
2014 247
2015 291
2016 293
2017 282
2018 292
2019 300
2020 369
2021 462
2022 492
2023 421
2024 456
2025 432
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,905 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial.
Paz-Ares L, Borghaei H, Liu SV, Peters S, Herbst RS, Stencel K, Majem M, Şendur MAN, Czyżewicz G, Caro RB, Lee KH, Johnson ML, Karadurmuş N, Grohé C, Baka S, Csőszi T, Ahn JS, Califano R, Yang TY, Kemal Y, Ballinger M, Cuchelkar V, Graupner V, Lin YC, Chakrabarti D, Bhatt K, Cai G, Iannone R, Reck M; IMforte investigators. Paz-Ares L, et al. Among authors: lin yc. Lancet. 2025 Jun 14;405(10495):2129-2143. doi: 10.1016/S0140-6736(25)01011-6. Epub 2025 Jun 2. Lancet. 2025. PMID: 40473449 Clinical Trial.
KIF2C promotes paclitaxel resistance by depolymerizing polyglutamylated microtubules.
Pao YS, Liao KJ, Shiau YC, Chao MH, Li MC, Lin LM, Chang HH, Yeh HW, Chen YJ, Chiu YT, Pan MY, Chang YH, Shen SY, Lin SY, Cheng HC, Lin YC, Sun YJ, Kuo CC, Hsieh HP, Wang LH. Pao YS, et al. Among authors: lin yc. Dev Cell. 2025 Aug 4;60(15):2097-2113.e8. doi: 10.1016/j.devcel.2025.03.004. Epub 2025 Mar 28. Dev Cell. 2025. PMID: 40157365 Free article.
5,905 results